ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 102,33
0,13%
Dow Jones
39 065,26
-1,53%
DAX
18 691,32
0,05%
Brent Oil
81,31
-0,27%
Bitcoin
67 639,96
-2,12%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Acasti Pharma Inc (ACST)

  7. Acasti Pharma Inc (ACST) Actualités

ACST Acasti Pharma Inc

2,65
-0,04 (-1,49%)
Après les heures de négociation
Dernière mise à jour : 22:30:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Acasti Pharma Inc ACST NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,04 -1,49% 2,65 22:30:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,63 2,63 2,7499 2,65 2,69
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
10/5/202422:11EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
09/5/202401:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202401:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202401:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202401:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202401:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202414:00EDGAR2Form 8-K - Current report
12/2/202413:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/1/202413:30EDGAR2Form 8-K - Current report
20/12/202322:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202322:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202313:30EDGAR2Form 8-K - Current report
13/11/202313:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
23/10/202322:30EDGAR2Form 8-K - Current report
16/10/202322:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
11/10/202322:30EDGAR2Form 8-K - Current report
06/10/202322:30EDGAR2Form S-3 - Registration statement under Securities Act of..
28/9/202301:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202314:10EDGAR2Form 8-K - Current report
05/9/202321:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202323:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
25/8/202322:21EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
25/8/202322:15EDGAR2Form DEF 14A - Other definitive proxy statements
11/8/202313:31EDGAR2Form 8-K - Current report
11/8/202313:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
24/7/202323:30EDGAR2Form 8-K - Current report
18/7/202322:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202322:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202322:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202322:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202322:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202322:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/7/202315:00PRNUSAcasti Announces WuXi Clinical as CRO to Conduct STRIVE-ON..
07/7/202314:30EDGAR2Form 8-K - Current report
07/7/202314:00PRNUSAcasti Pharma Announces 1-for-6 Reverse Stock Split
05/7/202322:00EDGAR2Form 8-K - Current report
05/7/202315:00PRNUSAcasti Announces Alignment with FDA on GTX-104 Pivotal Phase..
23/6/202313:00PRNUSAcasti Pharma Reports Fiscal Year 2023 Operational Results
22/6/202315:00PRNUSAcasti Announces Appointment of New Scientific Advisory..

Dernières Valeurs Consultées

NASDAQ
ACST
Acasti Pharma
LSE
65PE
Mound Fin.4 2cs
BIT
P77104
BNP Paribas
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés